InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2025-01-24 00:00:00 ET · period of report 2025-01-23 · accession 0001773751-25-000025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-24 2025-01-23 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $30.08 -27.1K 27.9K -49% -$815.1K
D 2025-01-24 2025-01-23 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $2.43 +27.1K 55.0K +97% +$65.8K
D 2025-01-24 2025-01-23 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -27.1K 1.51M -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-01-23 S D 27,098 $30.08 27,918 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.00 - $30.255. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Class A Common Stock 2025-01-23 M A 27,098 $2.43 55,016 D — —
3 Derivative Stock Option (right to buy) 2025-01-23 M D 27,098 $0.00 1,506,401 D $2.43 · — to 2030-06-16 27,098 Class A Common Stock (F3) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.